Earnings History Data for GSK plc (GSK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

GSK plc

GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	PM		GSK	GSK plc	78,510	1.27	1.16	1.26		36.95	-1.22 (-3.18%)	36.45	-1.72 (-4.51%)	33.67 - 45.92	11,309,911	4,360,000	740,339
GSK to acquire lupus drug candidate CMG1A46 for up to $850M [10/29/2024 12:11 PM] GSK Q3 2024 Earnings Preview [10/29/2024 11:46 AM] GSK reports Q3 result, confirms FY guidance [10/30/2024 5:19 AM] GSK dips as lower vaccine sales weigh on Q3 2024 results [10/30/2024 6:43 AM] GSK to acquire Chimagens CMG1A46 for autoimmune disease [2024-10-30 05:15AM] GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ... [2024-10-30 05:00AM] GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand [2024-10-30 03:43AM]
31-07-2024	PM		GSK	GSK plc	82,360	1.09	1.00	0.97	GSK reports Q2 results, updates FY guidance [7/31/2024 5:04 AM]	38.80	-0.97 (-2.44%)	39.30	-0.47 (-1.18%)	33.67 - 45.92	3,586,471	2,980,000	81,372
GSK shingles vaccine cuts dementia risk [7/30/2024 3:21 PM] GSK Q2 2024 Earnings Preview [7/30/2024 12:27 PM] GSK reports Q2 results, updates FY guidance [7/31/2024 5:04 AM] GSK dips as vaccine headwinds overshadow guidance raise [7/31/2024 7:35 AM]
01-05-2024	PM		GSK	GSK plc	85,650	1.09	0.94	0.90	GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwards [5/1/2024 2:59 AM]	42.58	1.14 (2.74%)	42.72	1.28 (3.09%)	33.33 - 43.84	3,969,989	2,950,000	53,879
GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwards [5/1/2024 2:59 AM] Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents [4/30/2024 12:18 PM] GSK Q1 2024 Earnings Preview [4/30/2024 11:39 AM]
31-01-2024	PM		GSK	GSK PLC Sponsored ADR	80,388	0.72	0.76	0.00	GSK reports Q4 results; Forecasts 5% to 7% turnover growth for 2024 [1/31/2024 7:11 AM]	39.45	0.36 (0.92%)	40.60	1.51 (3.86%)	33.20 - 41.31	6,068,732	3,460,000	948,316
GSK Q4 to spotlight vaccine business amid Arexvy rollout [1/30/2024 12:20 PM] GSK reports Q4 results; Forecasts 5% to 7% turnover growth for 2024 [1/31/2024 7:11 AM] GSK lifts long-term outlook; eyes 12 major launches from 2025 [1/31/2024 7:10 AM]
01-11-2023	PM		GSK	GSK plc	72,220	1.26	1.09	1.09	GSK reports Q3 results, raises FY23 guidance [11/1/2023 4:21 AM]	34.52	-1.18 (-3.31%)	34.31	-1.39 (-3.89%)	31.22 - 39.74	7,156,607	3,700,000	377,206
GSK seen reporting higher Q3 earnings in wake of forecast raise [10/31/2023 2:56 PM] GSK inks $1B deal to obtain rights to hepatitis B drug from J&J [10/31/2023 10:31 AM] GSK reports Q3 results, raises FY23 guidance [11/1/2023 4:21 AM] Strong sales of new RSV vaccine drives upgrade to GSK's outlook [11/1/2023 5:22 AM]
26-07-2023	PM		GSK	GSK plc	77,020	0.97	0.85	0.87	GSK Non-GAAP EPS of 38.80p, revenue of £7.18B; raises FY23 guidance [7/26/2023 5:43 AM]	35.84	0.14 (0.41%)	35.70	0.0 (0.00%)	28.47 - 43.70	3,856,421	2,930,000	89,146
GSK’s plans for RSV shot in focus ahead of Q2 2023 results [7/25/2023 1:55 PM] GSK, J&J tout Cabenuva preference over Gilead's Biktarvy [7/25/2023 12:25 PM] GSK Non-GAAP EPS of 38.80p, revenue of £7.18B; raises FY23 guidance [7/26/2023 5:43 AM] GSK lifts guidance as vaccine business outperforms in Q2 2023 [7/26/2023 9:46 AM]
26-04-2023	PM		GSK	GSK PLC Sponsored ADR	75,040	0.90	0.85	0.00	GSK Non-GAAP EPS of 37.0p, revenue of £6.95B; reaffirms FY23 guidance [4/26/2023 5:47 AM]	35.91	-0.99 (-2.70%)	37.00	0.09 (0.24%)	28.47 - 45.85	3,388,435	2,780,000	87,740
GSK Non-GAAP EPS of 37.0p, revenue of £6.95B; reaffirms FY23 guidance [4/26/2023 5:47 AM] GSK vaccine sales drive growth amid COVID products decline, affirms FY23 outlook [4/26/2023 5:04 AM] With GlaxoSmithKline up 5% YTD, will its Q1 earnings also shine? [4/25/2023 12:35 PM] GSK's Jemperli gets review in EU for expanded use in uterus cancer [4/25/2023 5:29 AM] EU publishes proposed reforms for pharma industry [4/26/2023 9:26 AM]
01-02-2023	PM	0:00 AM ET (Feb 1)	GSK	GSK plc	71,890	0.64	0.59	0.86		35.48	0.23 (0.64%)	35.32	0.06 (0.17%)	28.47 - 46.97	5,391,935	4,390,000	210,488
GSK Q4 results in focus with eye on future as potential blockbuster drug awaits FDA decision [1/31/2023 11:30 AM] GSK Q4 sales driven by vaccines as specialty medicines see decline; provides FY23 outlook [2/1/2023 5:08 AM] GSK Benlysta gets FDA orphan drug status for systemic sclerosis [2/1/2023 7:03 AM]
02-11-2022	PM	6:00 AM ET (Nov 2)	GSK	GSK plc	67,460	1.09	0.91	1.26	GSK Non-GAAP EPS of 46.90p, revenue of £7.8B; raises FY22 guidance and expect good momentum in 2023 [11/2/2022 3:16 AM]	33.12	-0.34 (-1.02%)	34.14	0.68 (2.03%)	28.46 - 46.97	6,526,950	6,400,000	223,598
GSK Non-GAAP EPS of 46.90p, revenue of £7.8B; raises FY22 guidance and expect good momentum in 2023 [11/2/2022 3:16 AM] All eyes on GSK Q3 results as RSV vaccine brings silver lining amid Zantac woes [11/1/2022 10:15 AM] Pfizer maternal RSV vaccine for infants shows 81.8% efficacy vs severe disease [11/1/2022 7:57 AM] GSK raises FY22 outlook as Q3 sales grow on Specialty Medicines, Shingrix [11/2/2022 5:05 AM] GSK RSV vaccine for older adults gets FDA priority review [11/2/2022 6:45 AM]
27-04-2022	PM		GSK	GlaxoSmithKline PLC	114,740	0.88	0.77	0.63	GlaxoSmithKline Non-GAAP EPS of £0.328, revenue of £9.8B beats by £950M [4/27/2022 2:32 AM]	45.48	1.10 (2.47%)	45.26	0.87 (1.96%)	37.31 - 46.97	4,804,664	4,350,000	27,120
ViiV, Pfizer and Roche top pharmas on corporate reputation according to patient groups [4/26/2022 5:50 PM] GlaxoSmithKline Non-GAAP EPS of £0.328, revenue of £9.8B beats by £950M [4/27/2022 2:32 AM] GSK Q1 sales soar on Shingrix vaccine, COVID therapy Xevudy; confirms outlook, impact on Xevudy margins in FY22 [4/27/2022 5:23 AM] Drug/Biotech Stocks' Apr 27 Q1 Earnings Roster: GSK, AMGN & More [Apr-26-22 11:44AM] Lloyds Boosts Outlook Despite Inflation Warning: The London Rush [Apr-27-22 02:38AM] GlaxoSmithKline earnings, revenue beat expectations [Apr-27-22 03:11AM] GSK beats forecasts on back of Covid and shingles treatments [Apr-27-22 02:58AM] Glaxo beats expectations with boost from Covid treatment [Apr-27-22 04:12AM] GlaxoSmithKline Beats Expectations Boosted by Covid-19 Treatment. The Stock Is Up. [Apr-27-22 04:55AM] GSK share price rises on COVID treatment boost [Apr-27-22 07:22AM] Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales [Apr-27-22 11:10AM] These 10 Stocks Are Soaring Today [Apr-27-22 03:19PM] GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine [Apr-27-22 03:34PM]
09-02-2022	PM		GSK	GlaxoSmithKline PLC	112,740	0.69	0.63	0.62	GlaxoSmithKline reports Q4 results [2/9/2022 4:25 AM]	44.26	-0.96 (-2.12%)	44.54	-0.68 (-1.50%)	33.53 - 46.85	3,677,726	4,770,000	99,213
GlaxoSmithKline reports Q4 results [2/9/2022 4:25 AM] GlaxoSmithKline FY21 revenue largely flat; on track for consumer unit spin-off [2/9/2022 5:05 AM] GlaxoSmithKline increases dividend by 21% [2/9/2022 5:12 AM] Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus [Feb-08-22 03:00PM] High drug prices due to complex health care system in the U.S., Novo Nordisk CEO says [Feb-08-22 10:10AM] Is GlaxoSmithKline (GSK) Outperforming Other Medical Stocks This Year? [Feb-08-22 09:40AM] GlaxoSmithKline sees profits fall despite £1.4bn Covid related sales [Feb-09-22 03:17AM] GSK racks up £1.4bn in COVID sales ahead of consumer health split [Feb-09-22 04:14AM] Technology stocks lead European markets higher as bond yields continue to ease [Feb-09-22 04:45AM] Glaxo Expects Profit to Rise as Drugmaker Readies for Split [Feb-09-22 04:51AM] European stock markets edge higher as global stocks rally [Feb-09-22 03:56AM] GSK vows step change in growth as it presses ahead with consumer arm spin-off [Feb-09-22 07:52AM] Glaxo (GSK) Beats Earnings and Revenues Estimates in Q4 [Feb-09-22 07:49AM] Market Futures Higher Ahead of Opening [Feb-09-22 11:06AM] Markets Stampede into the Green; CVS, GSK Beat, YUM Mixed [Feb-09-22 10:38AM] Glaxo boss clears path for sale of consumer business [Feb-09-22 11:29AM]
27-10-2021	PM		GSK	GlaxoSmithKline PLC	100,060	1.01	0.80	0.92	GlaxoSmithKline reports Q3 results, boost FY21 outlook [10/27/2021 7:08 AM]	40.42	0.24 (0.60%)	40.42	0.0 (0.00%)	33.26 - 42.68	7,251,016	4,180,000	13,168
Will GlaxoSmithKline Q3 results bring positive earnings surprise? [10/26/2021 1:07 PM] GlaxoSmithKline reports Q3 results, boost FY21 outlook [10/27/2021 7:08 AM] GlaxoSmithKline lifts 2021 earnings guidance; consumer unit returns to growth [10/27/2021 7:28 AM] Theraflu Launches the Rest & Recover Fund to Help More Americans Take a Sick Day When Needed [Oct-26-21 08:47AM] Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics Development [Oct-26-21 08:32AM] Drugs and vaccines help pharma giant GSK beat expectations [Oct-27-21 07:34AM] GSK Q3 results beat expectations as it gears up to sell consumer healthcare unit [Oct-27-21 09:34AM] GlaxoSmithKline Earnings Beat Expectations. The Embattled CEO Says Her Plan Is Working. [Oct-27-21 09:49AM] GlaxoSmithKline raises outlook and appoints genetics expert to board [Oct-27-21 10:00AM] Glaxo (GSK) Beats Earnings and Revenues Estimates in Q3 [Oct-27-21 10:19AM] GlaxoSmithKline Drops Research On Otilimab In COVID-19 [Oct-27-21 01:12PM]
28-07-2021	PM	0:00 AM ET (Jul 28)	GSK	GlaxoSmithKline PLC	98,170	0.79	0.54	0.48	GlaxoSmithKline EPS beats by £0.08, beats on revenue [7/28/2021 7:11 AM]	39.50	-0.02 (-0.05%)	39.50	0.0 (0.00%)	33.26 - 42.40	4,351,752	4,520,000	1,049
GSK, Vir Bio ink joint procurement agreement with EC for COVID-19 treatment, sotrovimab [7/28/2021 6:51 AM] GlaxoSmithKline EPS beats by £0.08, beats on revenue [7/28/2021 7:11 AM] GlaxoSmithKline posts Q2 earnings beat, maintains FY forecast [7/28/2021 8:20 AM] GlaxoSmithKline declares GBP 0.19 dividend [7/28/2021 9:54 AM] Theres a great opportunity that well have another variant: Doctor [Jul-27-21 02:12PM] Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY [Jul-27-21 11:14AM] European markets mixed on busy day of financial results [Jul-28-21 03:36AM] GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab [Jul-28-21 06:20AM] UPDATE 1-EU signs deal with GSK for supply of potential COVID drug [Jul-28-21 06:47AM] UPDATE 2-EU signs deal with GSK for supply of potential COVID drug [Jul-28-21 06:47AM] GSK encouraged by Covid vaccine rollout as sales and profits jump [Jul-28-21 07:38AM] Europe buys 220,000 doses of Vir, GSK's experimental COVID-19 treatment [Jul-28-21 08:51AM] Glaxo (GSK) Beats Earnings and Revenues Estimates in Q2 [Jul-28-21 07:25AM] European Commission To Procure 220K Doses Of Glaxo-Vir Biotech's COVID-19 Antibody [Jul-28-21 07:09AM] Glaxo Gets Vaccine Sales Boost and Covid-19 Efforts Start to Bear Fruit [Jul-28-21 11:07AM] Vaccine Demand Boosts GlaxoSmithKline's Q2 Sales, Earnings; Maintains FY21 Guidance [Jul-28-21 09:11AM] Covid-19 vaccine booster shots will become a reality: Doctor [Jul-28-21 01:51PM] GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript [Jul-28-21 06:00PM]
28-04-2021	PM		GSK	GlaxoSmithKline PLC	95,040	0.63	0.63	0.97	GlaxoSmithKline EPS beats by £0.01, misses on revenue [4/28/2021 7:07 AM]	37.70	-0.03 (-0.08%)	37.61	-0.12 (-0.32%)	33.26 - 43.18	2,567,730	6,450,000	148,879
GlaxoSmithKline EPS beats by £0.01, misses on revenue [4/28/2021 7:07 AM] GSK top-line down 18%; FY2021 guidance affirmed [4/28/2021 7:49 AM] CDCs latest guidance on outdoor mask wearing is a big milestone: Doctor [Apr-27-21 01:58PM] Is a Beat Likely for AstraZeneca (AZN) in Q1 Earnings? [Apr-27-21 09:32AM] Eli Lilly (LLY) Q1 Earnings Miss, COVID-19 Drug Demand Low [Apr-27-21 09:03AM] Should You Buy GlaxoSmithKline (GSK) Ahead of Earnings? [Apr-27-21 08:46AM] This Huge Win Could Boost Novavax's Fortunes -- and It Has Nothing to Do With COVID-19 [Apr-27-21 05:52AM] GlaxoSmithKline delivers profit beat, but sales disappoint [Apr-28-21 07:28AM] GSK sales slide as Covid vaccination delays other treatments [Apr-27-21 08:00PM] UPDATE 2-GSK focused on split as COVID curb easing helps earnings [Apr-28-21 07:20AM] GSK profit takes a hit amid COVID as activist fund builds up stake [Apr-28-21 08:27AM] UPDATE 3-GSK pursuing split as easing of COVID curbs aids earnings [Apr-28-21 07:20AM] FTSE 100 lifted by gains for energy heavyweights as well as Lloyds and WPP results [Apr-28-21 09:04AM] GSK chief defends against accusations of flat performance [Apr-27-21 08:00PM] GSK pursuing split as easing of COVID curbs aids earnings [Apr-28-21 09:40AM] GSK focused on split as cost checks, COVID-19 easings aid earnings [Apr-28-21 09:40AM] Glaxo (GSK) Miss Earnings and Revenues Estimates in Q1 [Apr-28-21 09:12AM] UPDATE 4-GSK focused on split as cost checks, COVID-19 easings aid earnings [Apr-28-21 07:20AM] GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook [Apr-28-21 10:04AM] Its good to lift COVID-19 restrictions right now: UAB Epidemiologist [Apr-28-21 01:32PM] GlaxoSmithKline plc (GSK) Q1 2021 Earnings Call Transcript [Apr-28-21 05:00PM]
03-02-2021	PM		GSK	GlaxoSmithKline PLC	93,910	0.62	0.70	0.64	GlaxoSmithKline EPS in-line, beats on revenue [2/3/2021 7:30 AM]	35.51	-1.51 (-5.55%)	36.00	-1.59 (-4.23%)	31.43 - 47.36	23,574,526	4,572,955	1,568,528
GlaxoSmithKline EPS in-line, beats on revenue [2/3/2021 7:30 AM] GSK, CureVac team up to develop COVID-19 vaccine targeting variants [2/3/2021 3:15 AM] GSK drops 5% on Q4 results, sees 2021 non-GAAP EPS down by mid to high single digit [2/3/2021 8:10 AM] GSK slumping premarket following Q4 results, but future catalysts may provide boost [2/3/2021 8:47 AM] GlaxoSmithKline declares GBP 0.23 dividend [2/3/2021 2:35 PM] 15 Biggest Corporate Fines in History [Feb-03-21 11:12AM] Glaxo (GSK) Miss Earnings Estimates in Q4, Revenues Beat [Feb-03-21 09:17AM] The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision [Feb-03-21 07:31AM] GSK and CureVac reveal new collaboration to work on vaccines [Feb-03-21 03:21AM] CureVac Shares Leap On COVID Vaccine Pact With GlaxoSmithKline [Feb-03-21 03:19AM] GSK and CureVac to Develop Next Generation MRNA COVID-19 Vaccines [Feb-03-21 02:40AM] GSK and CureVac to develop vaccines to tackle Covid variants [Feb-02-21 07:00PM] GlaxoSmithKline agrees tie-up with Nasdaq-listed CureVac to develop Covid-19 vaccines [Feb-02-21 07:00PM]
28-10-2020	PM		GSK	GlaxoSmithKline PLC	88,530	0.92	0.78	0.95	GlaxoSmithKline EPS beats by £0.06, misses on revenue [10/28/2020 8:11 AM]	33.98	-1.38 (-3.89%)	34.75	-0.60 (-1.70%)	31.43 - 48.25	7,086,112	5,266,906	59,028

29-07-2020	PM		GSK	GlaxoSmithKline PLC	102,550	0.48	0.49	0.78	GlaxoSmithKline EPS misses by £0.01, misses on revenue [7/29/2020 7:24 AM]	40.14	-0.46 (-1.12%)	39.79	-0.80 (-1.97%)	31.43 - 48.25	2,319,786	3,364,595	60,095